CVRX (STOCKS)
CVRx, Inc. Common Stock
$7.830000
+0.675000 (+9.43%)
Prev close: $7.155000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Kevin Hykes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $205.36M
- Employees
- 206
- P/E (TTM)
- -3.82
- P/B (TTM)
- 4.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $56.65M |
| Benefits Costs and Expenses | $109.98M |
| Cost Of Revenue | $8.31M |
| Costs And Expenses | $109.98M |
| Gross Profit | $48.34M |
| Operating Expenses | $99.61M |
| Selling, General, and Administrative Expenses | $88.47M |
| Research and Development | $11.13M |
| Operating Income/Loss | -$51.27M |
| Income/Loss From Continuing Operations After Tax | -$53.31M |
| Income/Loss From Continuing Operations Before Tax | -$53.32M |
| Income Tax Expense/Benefit | -$18.00K |
| Net Income/Loss | -$53.31M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$53.31M |
| Net Income/Loss Available To Common Stockholders, Basic | -$53.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.04 |
| Diluted Earnings Per Share | -$2.04 |
| Basic Average Shares | 26,084,709 |
| Diluted Average Shares | 26,084,709 |
| Assets | $104.79M |
| Current Assets | $101.65M |
| Inventory | $12.21M |
| Other Current Assets | $89.44M |
| Noncurrent Assets | $3.15M |
| Fixed Assets | $2.24M |
| Other Non-current Assets | $904.00K |
| Liabilities | $65.47M |
| Current Liabilities | $13.32M |
| Accounts Payable | $3.83M |
| Other Current Liabilities | $9.48M |
| Noncurrent Liabilities | $52.15M |
| Equity | $39.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $39.32M |
| Liabilities And Equity | $104.79M |
| Net Cash Flow From Operating Activities | -$40.17M |
| Net Cash Flow From Operating Activities, Continuing | -$40.17M |
| Net Cash Flow From Investing Activities | -$580.00K |
| Net Cash Flow From Investing Activities, Continuing | -$580.00K |
| Net Cash Flow From Financing Activities | $10.52M |
| Net Cash Flow From Financing Activities, Continuing | $10.52M |
| Exchange Gains/Losses | $5.00K |
| Net Cash Flow | -$30.23M |
| Net Cash Flow, Continuing | -$30.23M |
| Comprehensive Income/Loss | -$53.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$53.30M |
| Other Comprehensive Income/Loss | $2.00K |